A Systematic Review of Economic Evaluations Conducted for Interventions to Screen, Treat, and Manage Retinopathy of Prematurity (ROP) in the United States, United Kingdom, and Canada
Authors:
- 14 June 2022
- journal article
- review article
- Published by Taylor & Francis in Ophthalmic Epidemiology
- Vol. 30 (2) , 113-120
Abstract
A systematic literature review (SLR) of economic evaluations (EE) conducted for interventions to screen, treat, and manage retinopathy of prematurity (ROP) in the United States (US), United Kingdom...Keywords
Funding Information
- associated with the work featured in this
This publication has 36 references indexed in Scilit:
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of PrematurityNew England Journal of Medicine, 2011
- Telemedicine for Retinopathy of Prematurity Diagnosis: Evaluation and ChallengesSurvey of Ophthalmology, 2009
- Cost-utility analysis of screening and laser treatment of retinopathy of prematurityJournal of American Association for Pediatric Ophthalmology and Strabismus, 2009
- Cost-effectiveness of Early Treatment for Retinopathy of PrematurityPediatrics, 2009
- Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for controlEarly Human Development, 2008
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- Long term functional and structural outcomes of laser therapy for retinopathy of prematurityBritish Journal of Ophthalmology, 2006
- Retinopathy of Prematurity in Infants with Birth Weight ≥1250 Grams—Incidence, Severity, and Screening Guideline Cost-AnalysisJournal of American Association for Pediatric Ophthalmology and Strabismus, 2006
- Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening ProgramsPediatrics, 2005
- An International Classification of Retinopathy of PrematurityArchives of Ophthalmology (1950), 1984